| Page No 1 2 3 4 5 6 7 8 9 |
| Phrase | Consultant | Town | Special Interests |
| Palliative Medicine | *Consultant(s)* | *Towns* | Cancer care, ethical issues in palliative care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Cancer care, end-of-life care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Cancer pain management |
| Palliative Medicine | *Consultant(s)* | *Towns* | Paediatric palliative care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Pain and symptom control, medical education |
| Palliative Medicine | *Consultant(s)* | *Towns* | Nonmalignant palliative care, medical education |
| Palliative Medicine | *Consultant(s)* | *Towns* | Medical ethics |
| Palliative Medicine | *Consultant(s)* | *Towns* | End-of-life care |
| palliative medicine | *Consultant(s)* | *Towns* | Psychological supervision for NHS staff and other professionals, boarding school trauma, general psychological distress from all causes, palliative medicine |
| Palliative Medicine | *Consultant(s)* | *Towns* | Patients with learning disability who have a serious illness, medical education |
| Palliative Medicine | *Consultant(s)* | *Towns* | Medical education |
| Palliative Medicine | *Consultant(s)* | *Towns* | Optimum symptom control in end-of-life care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Symptom control, pain medicine, end of life care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Palliative care for nonmalignant disease |
| Palliative Medicine | *Consultant(s)* | *Towns* | Thrombosis, cancer and thrombosis |
| Palliative Medicine | *Consultant(s)* | *Towns* | End-of-life care, ethics |
| Palliative Medicine | *Consultant(s)* | *Towns* | Chronic heart failure, breathlessness |
| Palliative Medicine | *Consultant(s)* | *Towns* | Management of pain at the end-of-life |
| Palliative Medicine | *Consultant(s)* | *Towns* | Heart failure |
| Palliative Medicine | *Consultant(s)* | *Towns* | Lymphoedema, nonmalignant palliative care, community palliative care |
| Palliative Medicine | *Consultant(s)* | *Towns* | End-of-life care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Dementia, progressive neurological diseases |
| Palliative Medicine | *Consultant(s)* | *Towns* | Progressive neurological disorders |
| Palliative Medicine | *Consultant(s)* | *Towns* | Cancer care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Pain, patient involvement |
| Palliative Medicine | *Consultant(s)* | *Towns* | End-of-life care, nonmalignant palliative care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Breathlessness |
| Palliative Medicine | *Consultant(s)* | *Towns* | End-of-life care in the community setting |
| Palliative Medicine | *Consultant(s)* | *Towns* | Medical education |
| Palliative medicine | *Consultant(s)* | *Towns* | Palliative medicine |
| Palliative Medicine | *Consultant(s)* | *Towns* | End-of-life care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Ketamine as an analgesic, palliative care for non-cancer patients |
| Palliative Medicine | *Consultant(s)* | *Towns* | Renal failure |
| Palliative medicine | *Consultant(s)* | *Towns* | Palliative medicine, medical education especially postgraduate palliative care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Community palliative care, neuropathic cancer pain |
| Palliative Medicine | *Consultant(s)* | *Towns* | Cancer care, ethics |
| Palliative Medicine | *Consultant(s)* | *Towns* | Pain control, models of care |
| palliative medicine | *Consultant(s)* | *Towns* | Lung cancer, palliative medicine, general internal medicine |
| Palliative Medicine | *Consultant(s)* | *Towns* | Motor neurone disease |
| Palliative Medicine | *Consultant(s)* | *Towns* | Adult palliative care, symptom control, pain control |
| Palliative Medicine | *Consultant(s)* | *Towns* | Hospice based palliative care, ethical issues in end-of-life care |
| Palliative Medicine | *Consultant(s)* | *Towns* | Palliative chemotherapy, gynaecological oncology, complex pain management |
| Palliative Medicine | *Consultant(s)* | *Towns* | Feeding and nutrition at the end-of-life |
| Palliative Medicine | *Consultant(s)* | *Towns* | PI in MePFAC study: Methylphenidate v Placebo in management of fatigue in advanced cancer (RCT, double-blinded, trial completed), Sub PI in Chelsea II Study (Hydration at the end of life) |
| Palliative Medicine | *Consultant(s)* | *Towns* | Macmillan consultant, symptom management, education in palliative care, community palliative services |
| Palliative Medicine | *Consultant(s)* | *Towns* | Community specialist palliative care |
| Palliative Medicine | *Consultant(s)* | *Towns* | End-of-life care, pain management, palliative care, advance care planning |
| Palliative Medicine | *Consultant(s)* | *Towns* | Symptom control |
| palliative medicine | *Consultant(s)* | *Towns* | Clinical oncology, palliative medicine, lung cancer |
| Palliative Medicine | *Consultant(s)* | *Towns* | Degenerative neurological diseases, advance care planning |
| Page No 1 2 3 4 5 6 7 8 9 |
